Acorn Bioventures

Acorn Bioventures invests across stages in small-cap public and private biotechnology companies focused on bringing novel innovative medicines to patients. Our investment flexibility allows us to provide value across the entire spectrum from seed financings, cross-over financings, IPOs, registered direct offerings, PIPEs, open market purchases, etc. Management teams of our portfolio companies are our long-term partners and we are proud to be part of the entrepreneurial and pioneering spirit in biotech. Acorn Bioventures is structured to be able to provide committed capital to companies through multiple rounds of financing. Our investment process is based on fundamental research. We look for paradigm-changing medical therapies, undiscovered or underappreciated assets, backed by outstanding teams.